Literature DB >> 12771217

ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1.

Xueping Zhang1, Iman H Diab, Zendra E Zehner.   

Abstract

Vimentin, a member of the intermediate filament protein family, is regulated both developmentally and tissue specifically. It is also a marker of the metastatic potential of many tumor cells. Pre viously, the human vimentin promoter has been shown to contain multiple elements for the binding of both positive- and negative-acting regulatory factors. Transient transfection analysis of various vimentin 5'-end promoter sequences and mutants thereof fused to a reporter gene further defined two regulatory elements, a positive element that binds Sp1 and a negative element that binds the protein ZBP-89. ZBP-89 has been shown to be either a repressor or an activator of gene expression, depending on the promoter. Here, we show that for vimentin, both ZBP-89 and ZBP-99 repress reporter gene expression in Schneider (S2) cells. Deletion constructs confirm that the glutamine-rich region of Sp1 is required to enhance vimentin transcription, whereas the N-terminus of ZBP-89 is required to interact with Sp1 and repress gene expression. The overexpression of hTAF(II)130 can alleviate ZBP-89 repression in S2 cells, suggesting how ZBP-89 might serve to block gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771217      PMCID: PMC156715          DOI: 10.1093/nar/gkg380

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  67 in total

1.  Human stromelysin gene promoter activity is modulated by transcription factor ZBP-89.

Authors:  S Ye; C Whatling; H Watkins; A Henney
Journal:  FEBS Lett       Date:  1999-05-07       Impact factor: 4.124

2.  ZBP-89, a Krüppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter.

Authors:  J L Merchant; G R Iyer; B R Taylor; J R Kitchen; E R Mortensen; Z Wang; R J Flintoft; J B Michel; R Bassel-Duby
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

3.  Mutually exclusive interactions between factors binding to adjacent Sp1 and AT-rich elements regulate gastrin gene transcription in insulinoma cells.

Authors:  D C Chung; S J Brand; L G Tillotson
Journal:  J Biol Chem       Date:  1995-04-14       Impact factor: 5.157

4.  Negative regulation of Sp1 trans-activation is correlated with the binding of cellular proteins to the amino terminus of the Sp1 trans-activation domain.

Authors:  Y Murata; H G Kim; K T Rogers; A J Udvadia; J M Horowitz
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

5.  The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator.

Authors:  L I Chen; T Nishinaka; K Kwan; I Kitabayashi; K Yokoyama; Y H Fu; S Grünwald; R Chiu
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

6.  Regulation of vimentin gene transcription in human breast cancer cell lines.

Authors:  C L Sommers; J M Skerker; S A Chrysogelos; M Bosseler; E P Gelmann
Journal:  Cell Growth Differ       Date:  1994-08

7.  Histone deacetylase 1 can repress transcription by binding to Sp1.

Authors:  A Doetzlhofer; H Rotheneder; G Lagger; M Koranda; V Kurtev; G Brosch; E Wintersberger; C Seiser
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

8.  Molecular characterization of the ets-related human transcription factor ER81.

Authors:  D Monté; L Coutte; J L Baert; I Angeli; D Stéhelin; Y de Launoit
Journal:  Oncogene       Date:  1995-08-17       Impact factor: 9.867

9.  Expression of the mouse pre-T cell receptor alpha gene is controlled by an upstream region containing a transcriptional enhancer.

Authors:  B Reizis; P Leder
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

10.  Sp1-mediated transcriptional activation is repressed by Sp3.

Authors:  G Hagen; S Müller; M Beato; G Suske
Journal:  EMBO J       Date:  1994-08-15       Impact factor: 11.598

View more
  29 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease.

Authors:  Roshni Srivastava; Jiasheng Zhang; Gwang-Woong Go; Anand Narayanan; Timothy P Nottoli; Arya Mani
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

3.  Sp3 proteins negatively regulate beta myosin heavy chain gene expression during skeletal muscle inactivity.

Authors:  Gretchen Tsika; Juan Ji; Richard Tsika
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  The Epstein-Barr virus protein BMRF1 activates gastrin transcription.

Authors:  Elizabeth A Holley-Guthrie; William T Seaman; Prasanna Bhende; Juanita L Merchant; Shannon C Kenney
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members.

Authors:  Yongzhong Wu; Xueping Zhang; Morgan Salmon; Xia Lin; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2006-12-06

6.  Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program.

Authors:  Morgan Salmon; Gary K Owens; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2009-02-14

7.  Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity.

Authors:  Rungnapa Hirunsatit; Elizabeth D George; Barbara K Lipska; Hani M Elwafi; Lisa Sander; Carolyn M Yrigollen; Joel Gelernter; Elena L Grigorenko; Jaakko Lappalainen; Shrikant Mane; Angus C Nairn; Joel E Kleinman; Arthur A Simen
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

8.  Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells.

Authors:  Avani R Vyas; Shivendra V Singh
Journal:  Eur J Nutr       Date:  2013-10-04       Impact factor: 5.614

9.  MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection.

Authors:  Xueping Zhang; Amy Ladd; Ema Dragoescu; William T Budd; Joy L Ware; Zendra E Zehner
Journal:  Clin Exp Metastasis       Date:  2009-09-22       Impact factor: 5.150

10.  Transcription factor ZBP-89 is required for STAT1 constitutive expression.

Authors:  Longchuan Bai; Juanita L Merchant
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.